Evidence available on 21 September 2026
The exact plus-sign query during the 21 September research returned network coverage using Spike 500 Amrix without the plus sign. The discovery did not establish common ownership or conditions for the exact Spike +500 Amrix offer. No accepted-country list or account classification was authenticated. We do not import a leverage figure or regulatory statement from those other articles, and no register-search outcome is claimed here.
Risk comparisons need the same account category
Before comparing two quoted scenarios, ask whether both apply to the same type of customer and the same product. A difference in residence, account category or agreement could make the figures answer different questions. The provider should state those assumptions beside the example rather than leave the reader to infer them. These are conditions for a fair future comparison, not categories that this review has verified for Spike +500 Amrix.
Evidence needed for a measured assessment
The record would improve with an attributable offer specifying the applicable customer conditions and a worked example using them. It would first need to identify the exact provider and explain any relationship to the punctuation-free variant. No account eligibility or trading behaviour was tested. The verdict remains unknown, with the plus sign and number retained as name elements rather than treated as evidence of a defined exposure.